Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Test Your Knowledge Previous | All Articles This Week | Next
This article originally posted 17 December, 2010 and appeared in  Issue 552, Best of GLP-1, Genetics of Diabetes

TYK #552: Which one of the following statements about glucagon-like peptide 1 (GLP-1) is not true?

Which one of the following statements about glucagon-like peptide 1 (GLP-1) is not true?
Advertisement

1. It is a peptide that is constantly secreted at basal levels from the colon.

2. Its levels are decreased in people with Type 2 diabetes.

3. It enhances glucose-dependent insulin secretion.

4. It inhibits glucagon secretion.

5. It has a very short plasma half-life.
 

Click here for correct answer.

Related Articles

Beta-Cell Dysfunction May Drive Diabetes in Asians Transforming Alpha Cells into New Diabetic Treatment Sleep Deprivation Suppresses Genes Linked to Metabolism
Advertisement

 

Bookmark and Share | Print | Category | Home

This article originally posted 17 December, 2010 and appeared in  Issue 552, Best of GLP-1, Genetics of Diabetes

Past five issues: Issue 677 | Diabetes Clinical Mastery Series Issue 136 | Issue 676 | Diabetes Clinical Mastery Series Issue 135 | Issue 675 |

 
Diabetes In Control Advertisers
 
Cast Your Vote
What test do you use to screen for prediabetes?

Navigate Diabetes In Control

Cardiovascular CE & CME Clinical Slides Drugs Affecting BG Safety Tools Test Your Knowledge Medications Polls Obesity Case Studies Jobs Interviews GLP-1 Agonist Sheri R. Colberg, PhD SGLT-2

 

Free Weekly Newsletter
Sign up here.

Free CE Available
CE Programs on diabetes

Search Articles On Diabetes In Control